RKDA Earnings Arcadia Biosciences, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -2.11 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -1.71 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -0.73 | 2025-11-07 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.36 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | 1.90 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -5.17 | 2026-03-26 | 10-K |
| Q3 2025 | 2024-09-30 | -2.18 | 2025-11-07 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.00 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.78 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -11.29 | 2025-03-25 | 10-K |
| Q3 2024 | 2023-09-30 | -9.31 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -7.70 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -10.86 | 2024-05-13 | 10-Q |
| FY 2022 | 2022-12-31 | -25.65 | 2023-03-30 | 10-K |
| Q3 2023 | 2022-09-30 | -19.37 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -14.90 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -8.09 | 2023-05-15 | 10-Q |
| FY 2022 | 2021-12-31 | -27.56 | 2023-03-30 | 10-K |
| Q3 2022 | 2021-09-30 | -0.26 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.15 | 2022-08-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.